Nisa Investment Advisors’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.4K Buy
566
+326
+136% +$22.4K ﹤0.01% 1924
2026
Q1
$15.3K Hold
240
﹤0.01% 2105
2025
Q4
$19.1K Sell
240
-53
-18% -$4.48K ﹤0.01% 1961
2025
Q3
$19.4K Buy
293
+9
+3% +$535 ﹤0.01% 2012
2025
Q2
$15K Buy
284
+203
+251% +$9.54K ﹤0.01% 2076
2025
Q1
$4.02K Sell
81
-2
-2% -$111 ﹤0.01% 2302
2024
Q4
$5.26K Buy
83
+44
+113% +$2.54K ﹤0.01% 2267
2024
Q3
$1.92K Buy
39
+7
+22% +$329 ﹤0.01% 2408
2024
Q2
$1.44K Buy
32
+22
+220% +$748 ﹤0.01% 2434
2024
Q1
$623 Buy
+10
New +$648 ﹤0.01% 2464
2023
Q4
Sell
-9
Closed -$423 2686
2023
Q3
$423 Buy
+9
New +$450 ﹤0.01% 2555

Other funds holding IRON

Nisa Investment Advisors's IRON Position: Q2 2026 in Review

Nisa Investment Advisors increased its Disc Medicine (IRON) stake by 136% in Q2 2026, buying an estimated $22.4K and bringing the position to 566 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Nisa Investment Advisors first reported a position in IRON in Q3 2023 and has held it in 11 quarters since. 61 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Nisa Investment Advisors held 566 shares of Disc Medicine worth $41.4K as of Q2 2026.
  • Nisa Investment Advisors bought 326 Disc Medicine shares in Q2 2026, an estimated $22.4K.
  • Disc Medicine made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1924 holding.
  • Nisa Investment Advisors first reported a position in Disc Medicine in Q3 2023 and has held it in 11 quarters since.
  • 61 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.